Your browser doesn't support javascript.
loading
Progesterone receptor heterogeneity and endometrial tumour differentiation.
Cheng, C; Bui, C; Cauchi, M.
Afiliação
  • Cheng C; Department of Pathology, Royal Women's Hospital, Melbourne, Victoria, Australia.
Cancer Lett ; 43(3): 215-8, 1988 Dec 15.
Article em En | MEDLINE | ID: mdl-3203339
ABSTRACT
Progesterone binding components were isolated using fast protein liquid chromatography (FPLC) with a recovery efficiency of between 60-70%. In normal uterine cytosol, the two components were in about equal proportions. In endometrial cancer, the ratio of peak size between peaks 1 and 2 was 1.5 for Grade I, 3.7 for Grade II and 2.5 for Grade III. Whether estimation of the levels of the two progesterone components separately would enhance predictability of response to hormone therapy in endometrial cancer remains to be established.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Receptores de Progesterona Limite: Female / Humans Idioma: En Ano de publicação: 1988 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Receptores de Progesterona Limite: Female / Humans Idioma: En Ano de publicação: 1988 Tipo de documento: Article